Nursing care
Why does isoniazid cause peripheral neuropathy, and who needs vitamin B6?
Written and reviewed by Nicole Ramirez, BSN, RN, CMSRN · 4 min read · Updated November 2026
Short answer
Isoniazid causes peripheral neuropathy because it binds and inactivates pyridoxine (vitamin B6), which nerves need to work normally. The resulting functional B6 deficiency usually starts as tingling or numbness in the feet and hands. Pyridoxine is given alongside isoniazid to clients at higher risk, such as those who are malnourished, diabetic or who drink heavily.
How isoniazid uses up vitamin B6
Isoniazid is a hydrazine compound. It combines with pyridoxine and its active form, pyridoxal phosphate, to make an inactive product that the kidneys excrete. The body's working supply of B6 drops even when the client eats a normal diet, which is why this is called a functional deficiency rather than a dietary one.
Pyridoxal phosphate is a cofactor for many nerve enzymes, including the one that makes GABA, the brain's main calming neurotransmitter. At treatment doses the deficit shows up in the peripheral nerves, starting in the feet and hands. In a large overdose the same B6 loss drops brain GABA sharply, which is why isoniazid poisoning causes seizures that pyridoxine reverses.
Who is at higher risk, and why
The isoniazid label lists malnourished clients, people with alcohol use disorder, people with diabetes and slow acetylators as more likely to develop neuropathy. The first three groups often start with lower B6 stores or nerves already under strain. Slow acetylators break isoniazid down more slowly, so drug levels run higher and more B6 is tied up.
Acetylator status is common, not rare. The label notes that about half of Black and white populations are slow acetylators. The label's recommendation is pyridoxine for the malnourished and for anyone predisposed to neuropathy, so a client in any of these groups should be on it.
What to assess and teach
According to the label, neuropathy is usually preceded by paresthesias of the feet and hands. Ask specifically about tingling, numbness, burning or pins and needles, because clients may not link these to a TB pill. CDC lists persistent numbness, pain, tingling or hot or cold sensations in the hands or feet as side effects needing medical attention.
Teach the client to take pyridoxine if it is prescribed with the regimen and to report new numbness or tingling early, because CDC lists persistent nerve symptoms as a reason to stop the medicine and get medical attention. The prescriber, not the client, decides whether and how to restart, since missed doses matter for TB cure. Fall risk teaching fits if foot numbness is already present.
The liver warning that outranks the tingling
Neuropathy develops slowly and is preventable. Hepatitis from isoniazid can be severe, and the label carries a boxed warning: risk rises with age and with daily alcohol use. Clients should report loss of appetite, nausea, vomiting, dark urine, yellow skin or eyes, rash, or fatigue, weakness or fever lasting more than a few days.
CDC guidance advises withholding the drug if transaminases exceed three times the upper limit of normal with symptoms, or five times without symptoms. Baseline liver tests are recommended for clients with liver disease, HIV, pregnancy or regular alcohol use. When an exam stem gives both tingling feet and dark urine, the dark urine is the finding to act on first.
Hypothetical practice scenario
Hypothetical scenario, not a real exam item: a client with diabetes starts isoniazid for latent TB. Which statement shows the teaching worked: "I will take vitamin B6 every day with my TB pill," "I will wait to mention foot tingling at my next visit," or "Mild nausea and darker urine are normal at first"?
The vitamin B6 statement is correct, since diabetes raises neuropathy risk and pyridoxine counters the B6 loss. Waiting to mention tingling lets a preventable neuropathy progress, since early reporting is what the teaching is for. Calling nausea and dark urine normal is the dangerous one, because together they suggest isoniazid hepatitis.
Sources and further reading
Isoniazid tablets, USP: FDA prescribing information (DrugCentral label view). Boxed hepatitis warning with age and alcohol risk; symptoms to report; neuropathy risk groups; paresthesias first; pyridoxine for malnourished and predisposed; slow acetylator frequency.
CDC: Treatment for Latent Tuberculosis Infection (clinical guidance). Neuropathy symptoms needing attention, hepatotoxicity signs, transaminase withholding thresholds, baseline liver testing groups.
American Family Physician: Isoniazid Overdose, Recognition and Management. Isoniazid combines with and inactivates pyridoxine, lowering GABA and causing seizures in overdose that pyridoxine reverses.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why does isoniazid cause peripheral neuropathy?
Isoniazid binds pyridoxine and its active form, making an inactive compound that is excreted in urine. Nerves lose a cofactor they need, and the result is a sensory neuropathy that usually starts as tingling or numbness in the feet and hands.
Why is vitamin B6 given with isoniazid?
Pyridoxine replaces the B6 that isoniazid ties up, which lowers the chance of neuropathy. The label recommends it for clients who are malnourished or predisposed to neuropathy, such as those with diabetes or alcohol use disorder, and prescribers may give it more widely.
What liver signs should be reported on isoniazid?
Loss of appetite, nausea, vomiting, dark urine, jaundice, rash, and fatigue, weakness or fever lasting more than a few days. These can signal drug-induced hepatitis, and clients are taught to stop the drug and seek care promptly.
More on pharmacology
Guides on this